¥256 2.0 0.8%
Last Trade - 15/01/21
Market Cap | £28.8m |
Enterprise Value | £20.8m |
Revenue | £1.05m |
Position in Universe | 3259th / 3893 |
Feb 15 (Reuters)- CellSeed Inc. CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Dec 31, 2018 Dec 31, 2017 Dec 31, 2019 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 1.03 85 mln 300 mln 180 mln (-15.5 pct) (+29.2 pct) (+51.7 pct) Operating 140 mln loss 956 mln loss 1.10 loss 450 mln Recurring 140 mln loss 964 mln loss 1.10 loss 450 mln Net Net 129 mln loss 966 mln loss 1.10 loss 450 mln EPS 11.35 yen loss 93.29 yen loss 95.99 yen loss 39.27 yen EPS Diluted 11.27 yen Ann Div NIL NIL NIL -Q2 Div NIL NIL NIL -Q4 Div NIL NIL NIL NOTE - CellSeed Inc.. *Second Net profit row denotes profit attributable to owners ofthe parent To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T